Xylose

Xylose

SCHEMBL22729263

COC(=O)C(CCCCN)NC(=O)CNC(C)=O.O=CC(O)C(O)C(O)CO

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FURIN P09958 2/20 0.37
FAP Q12884 1/20 0.34
NMT2 O60551 1/20 0.34
NMT1 P30419 1/20 0.34
SIRT6 Q8N6T7 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
SLC6A5 Q9Y345 1/20 0.34
ERAP2 Q6P179 6/20 0.33
LNPEP Q9UIQ6 6/20 0.33
ERAP1 Q9NZ08 2/20 0.33
HDAC2 Q92769 1/20 0.32
CYP2C9 P11712 1/20 0.32
PRSS1 P07477 1/20 0.31
CNR2 P34972 1/20 0.31
TLR2 O60603 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4653470 0.84 FURIN (0.45) FURINFAPNMT2NMT1SIRT6
SCHEMBL4653469 0.84 FURIN (0.45) FURINFAPNMT2NMT1SIRT6
SCHEMBL468887 0.71 SLC6A5 (0.54) SIRT6SIRT1SLC6A5
SCHEMBL468889 0.71 SLC6A5 (0.54) SIRT6SIRT1SLC6A5
SCHEMBL2387748 0.71 SIRT6 (0.54) FURINSIRT6SIRT1ERAP2LNPEP
SCHEMBL5494276 0.71 SIRT6 (0.54) FURINSIRT6SIRT1ERAP2LNPEP
SCHEMBL27839515 0.70 PAOX (0.42) SIRT6SIRT1SLC6A5TLR2
Demannose SCHEMBL26657950 0.70 FOLH1 (0.40) NMT2NMT1SLC6A5
Galactose SCHEMBL9221802 0.70 FOLH1 (0.40) NMT2NMT1SLC6A5
SCHEMBL27846706 0.70 ERAP2 (0.43) NMT2NMT1SIRT6SIRT1SLC6A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3747435-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES COMPLICATIONS COMPRISING NOVEL CHRYSIN DERIVATIVE COMPOUND AS ACTIVE INGREDIENT FRONTBIO INC. (KR) 2020-12-09 EP disclosed
CN-111655254-A Pharmaceutical composition for preventing or treating diabetic complications comprising novel chrysin derivative compounds as active ingredients 先生株式会社 2020-09-11 CN disclosed